What is AbCellera Biologics Inc.'s canada — long-term assets?

AbCellera Biologics Inc. (ABCL) reported canada — long-term assets of $81M in Q4 2025.

How has AbCellera Biologics Inc.'s canada — long-term assets changed year-over-year?

AbCellera Biologics Inc.'s canada — long-term assets decreased by 84.0% year-over-year, from $505.1M to $81M.

What does canada — long-term assets mean?

Represents the book value of non-current assets, such as property, plant, equipment, and intangible assets, located or utilized within the Canadian segment. This metric reflects the scale of the company's long-term physical and strategic investment in its Canadian infrastructure.

AbCellera Biologics Inc. ABCL Canada — Long-term assets

Similar metrics at other companies

IPGPCanada — Long-Lived Assets

$17.01M+25.8%

SONCANADA — Long-Lived Assets

$27.21M-23.9%

WERNCanada — Long-Lived Assets

$60K-18.9%

TTEKCanada — Long-Lived Assets

$7.18M-12.2%

LPXCanada — Long lived assets

$439M-6.2%

BDCCanada — Long-Lived Assets

$16.59M+20.2%

Other financials

Income statement

See full

Revenue$8.3M+96.3%

Operating income-$57.5M+8.2%

Net income-$43.2M+5.4%

EPS (diluted)-$0.14+6.7%

Balance sheet

See full

Cash & equivalents$102.1M-44.6%

Total debt$140.2M+107%

Total equity$938.1M-8.3%

Total assets$1.3B-2.8%

Cash flow

See full

Operating cash flow-$33.5M-190%

CapEx$3.8M-64.0%

Free cash flow-$37.4M-68.3%

Valuation

See full

Market cap$1.84B+80.9%

Enterprise value$1.88B+109%

P/S23.3×-20.8×

Profitability

See full

Operating margin-267.6%-120pp

Net margin-181.7%-77.9pp

FCF margin-238.9%-90.9pp

Returns & leverage

See full

Return on equity-14.7%-0.8pp

Debt / equity0.1×+0.1×

Current ratio14.1×+3.9×

Where this comes from

Reported directly by AbCellera Biologics Inc. in its filing.

Tagged under the XBRL concept us-gaap:AssetsDesignatedToClosedBlockOtherLongTermInvestments.

The official record: AbCellera Biologics Inc.’s 10-K, filed February 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about AbCellera Biologics Inc.'s canada — long-term assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AbCellera Biologics Inc.'s canada — long-term assets?: AbCellera Biologics Inc. (ABCL) reported canada — long-term assets of $81M in Q4 2025.
How has AbCellera Biologics Inc.'s canada — long-term assets changed year-over-year?: AbCellera Biologics Inc.'s canada — long-term assets decreased by 84.0% year-over-year, from $505.1M to $81M.
What does canada — long-term assets mean?: Represents the book value of non-current assets, such as property, plant, equipment, and intangible assets, located or utilized within the Canadian segment. This metric reflects the scale of the company's long-term physical and strategic investment in its Canadian infrastructure.